CAS No. |
2231068-83-8 |
|---|---|
英文名称 |
- |
别名 |
Mavezelimab;Research Grade Favezelimab (DHD30402);Favezelimab (anti-LAG3) |
用途 |
Mavezelimab is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II; it has potential for use in combination with the PD-L1 inhibitor pembrolizumab in research on colorectal cancer (CRC). |
|
|
评论 |
|---|